Summary
- Current Price
- As of today, CPRX price is $31.49
- Current Price All-Time High
- CPRX price is currently -3.29% below its historical high of $32.56 set on
- Market Cap
- CPRX current market cap is $4B, up +60.38% over the past 365 days
- PE Ratio
- CPRX current PE ratio is 18.10
- Revenue
- CPRX current annual revenue is $588.99M, up +19.78% year-over-year
- Next Earnings
- As of today, the next earnings release for CPRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Catalyst Pharmaceuticals Inc |
| Ticker | NASDAQ: CPRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | catalystpharma.com |
| Employees | 182 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $31.49 | |
| Price, 1D Change | - | |
| $4B | ||
| - | ||
| 18.10 | ||
| 0.64 | ||
| $588.99M | ||
| Revenue, 1Y Change | +19.78% | |
| $1.68 | ||
| EPS, 1Y Change | +28.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.68 | ||
| EPS Estimate | $3.17 | N/A |
| EPS Est. Change | +88.46% | N/A |
| $588.99M | ||
| Revenue Estimate | $636.20M | N/A |
| Revenue Est. Change | +8.02% | N/A |
| Current Price | $31.49 | |
| Price Target | $31.50 | - |
| Price Tgt. Change | +0.03% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.06 | $1.31 | -36.25% | |
| $2.54 | $1.68 | -33.73% | |
| $3.17 | N/A | +88.46% | |
| $3.18 | N/A | +88.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $484.10M | $491.73M | +1.58% | |
| $579.13M | $588.99M | +1.70% | |
| $636.20M | N/A | +8.02% | |
| $717.90M | N/A | +21.89% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $31.49 | |
| $25.64 | ||
| $31.35 | ||
| $26.76 | ||
| $30.71 | ||
| $0.12 | ||
| 0.64 | ||
| $0.05 | ||
| 70.25 | ||
| 0.39% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $588.99M | ||
| $1.68 | ||
| $464.24M | ||
| 78.82% | ||
| $257.78M | ||
| 43.77% | ||
| $214.33M | ||
| 36.39% | ||
| $295.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 6.08 | ||
| 5.82 | ||
| - | ||
| 6 | ||
| 17.87 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 18.10 | ||
| 6.46 | ||
| 3.81 | ||
| 10.13 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $954.27M | ||
| $709.17M | ||
| $1.11B | ||
| $894.03M | ||
| $152.54M | ||
| $147.15M | ||
| $2.79M | ||
| $437.00K | ||
| $11.20M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $374.66M | ||
| $206.46M | ||
| $124.75M | ||
| $0.00 | ||
| $38.17M | ||
| $0.00 | ||
| $69.19M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $208.67M | ||
| -$58.00K | ||
| -$16.99M | ||
| $58.00K | ||
| $208.61M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Stephens & Co. | → | |
| Citigroup | → | |
| Citigroup | → | |
| Baird | → | |
| HC Wainwright & Co. | → | |
| Stephens & Co. | → | |
| Baird | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CPRX
FAQ
- What is the ticker symbol for Catalyst Pharmaceuticals Inc?
- The ticker symbol for Catalyst Pharmaceuticals Inc is NASDAQ:CPRX
- Does Catalyst Pharmaceuticals Inc pay dividends?
- No, Catalyst Pharmaceuticals Inc does not pay dividends
- What sector is Catalyst Pharmaceuticals Inc in?
- Catalyst Pharmaceuticals Inc is in the Healthcare sector
- What industry is Catalyst Pharmaceuticals Inc in?
- Catalyst Pharmaceuticals Inc is in the Biotechnology industry
- What country is Catalyst Pharmaceuticals Inc based in?
- Catalyst Pharmaceuticals Inc is headquartered in United States
- When did Catalyst Pharmaceuticals Inc go public?
- Catalyst Pharmaceuticals Inc initial public offering (IPO) was on November 8, 2006
- Is Catalyst Pharmaceuticals Inc in the S&P 500?
- No, Catalyst Pharmaceuticals Inc is not included in the S&P 500 index
- Is Catalyst Pharmaceuticals Inc in the NASDAQ 100?
- No, Catalyst Pharmaceuticals Inc is not included in the NASDAQ 100 index
- Is Catalyst Pharmaceuticals Inc in the Dow Jones?
- No, Catalyst Pharmaceuticals Inc is not included in the Dow Jones index
- When was Catalyst Pharmaceuticals Inc last earnings report?
- Catalyst Pharmaceuticals Inc's most recent earnings report was on August 5, 2026
- When does Catalyst Pharmaceuticals Inc report earnings?
- The date for Catalyst Pharmaceuticals Inc's next earnings report has not been announced yet
Data Sources & References
- CPRX Official Website catalystpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1369568/000119312526071525/0001193125-26-071525-index.htm
- CPRX Profile on Yahoo Finance finance.yahoo.com/quote/CPRX
- CPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cprx
